Resource utilization among individuals dying of pediatric life-threatening diseases

Negar Chavoshi1, Tanice Miller, Harold Siden

  • 11 University of British Columbia , Vancouver, British Columbia.

Insights

Children and young adults with life-threatening diseases (LTDs) used extensive healthcare resources, including hospitalizations and medical services, highlighting the need for enhanced pediatric palliative care.

Area of Science:

  • Pediatric Oncology
  • Palliative Care
  • Healthcare Resource Utilization

Background:

  • Limited data exists on healthcare resource use for pediatric patients with life-threatening diseases (LTDs).
  • Understanding end-of-life (EOL) care needs is crucial for this population.

Purpose of the Study:

  • To quantify end-of-life (EOL) resource utilization in pediatric patients dying from LTDs in British Columbia, Canada.
  • To analyze hospital discharges, hospital days, and medical services used.

Main Methods:

  • Utilized Vital Statistics data from British Columbia (2002/03–2006/07).
  • Included three age groups: infants (<1 year), children/adolescents (1–19 years), and young adults (20–24 years).
  • Calculated annual rates of hospital discharges, days in hospital, and medical services for LTD deaths.

Main Results:

  • Pediatric LTD patients experienced high resource utilization, with 5.3 discharges and 48 hospital days in the year of death.
  • Young adults (20-24) had 3.7 discharges and 39 days in hospital.
  • Infants (<1 year) averaged 1 discharge and 21 medical services.

Conclusions:

  • Resource utilization was substantial across all pediatric age groups dying from LTDs.
  • Findings underscore the critical need for robust palliative care services for children and young adults with LTDs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Life Tables01:22

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...